# Doxorubicin Hydrochloride

NDC: 16714-742
Generic name: Doxorubicin Hydrochloride
Labeler / Manufacturer: NorthStar RxLLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTABLE, LIPOSOMAL
Routes: INTRAVENOUS
Marketing started: 20170829

FDA application: ANDA208657

## Active ingredients

- DOXORUBICIN HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16714-742"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16714-742
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67417a18-e0f4-c9a0-e152-b8d8dc934af6